Trial Profile
Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea. A Pilot, Dose Finding, Double-blind, Randomized, Multicentre Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2020
Price :
$35
*
At a glance
- Drugs Rifamycin (Primary)
- Indications Diarrhoea; Intestinal infections
- Focus Therapeutic Use
- Sponsors Cosmo Technologies
- 28 Feb 2018 New trial record